- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in sanofi
Sanofi, GSK Launch Trial For COVID-19 Protein-based Vaccine
If the results are conclusive, Sanofi and GSK hope to get the vaccine approved in the first half of next year.
Read MoreSanofi, GSK Launch Trial For COVID-19 Protein-Based Vaccine
Sanofi and GSK said on Thursday that they had started the "Phase 1/2" trial for their adjuvanted COVID-19 vaccine, which they hope to make available across the world.
Read MoreSanofi Snags Another US Biotech Asset With $3.7 Billion Deal For Principia Biopharma
Sanofi shares edged up 0.6% in early session trading, bucking a slight fall in France's CAC-40 index, as analysts were positive on the deal.
Read MoreEU In Talks To Secure Sanofi Deal For Coronavirus Vaccine
The European Commission wants to strike deals with up to six drugmakers for their vaccines for their 450 million citizens against the coronavirus that has killed 674,000 people worldwide.
Read MoreSanofi Eyes Approval Of COVID-19 Vaccine By First Half Of 2021
There are currently no vaccines to prevent the coronavirus that has infected more than 9 million people and killed over 469,000 globally, and only a couple of medicines that have demonstrated benefit in hospitalized COVID-19 patients in clinical trials.
Read MoreSanofi Eyes Approval Of COVID-19 Vaccine By First Half Of 2021
Sanofi, which is hosting a virtual research and development event, and GSK had said in April the vaccine, if successful, would be available in the second half of 2021.
Read MoreMNC Pharma: Opportunity In The Middle Of A Crisis!
MNC stocks like prized diamonds collected over a period of time and not bought one fell swoop. So be patient but keep a close eye on these two gems!!
Read MoreSanofi To Run Consultations Over Restart Of Hydroxychloroquine Trials
"We will review available information and run consultations in the coming days to reassess our position," a spokesman with Sanofi said.
Read MoreSanofi Stops Enrolling COVID-19 Patients In Hydroxychloroquine Trials Amid Safety Concerns
The moves come after the World Health Organization paused its large trial of hydroxychloroquine after the British journal The Lancet reported patients getting the drug had increased death rates and irregular heartbeats.
Read MoreDrugmaker Sanofi To Raise Over $11 Billion Via Sale Of Regeneron Shares
Sanofi is selling the Regeneron shares at $515.00 per share - a discount of around 5.5% to Regeneron's closing price of $545.21 on May 26, and raising gross proceeds of $11.1 billion.
Read MoreSanofi Says COVID-19 Vaccine Will Be Available Worldwide Simultaneously
The group's chief executive Paul Hudson said on Thursday it was vital that any coronavirus vaccine reach all parts of the world
Read MoreUS Priority On Sanofi Virus Vaccine Would Be Unacceptable, Says France
The companies have received financial support from the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Health Department.
Read MoreSanofi Confirms Targets, Strong Demand For Pain Killers Lifts First Quarter
Net income was up 16.1% at constant exchange rates in the first quarter to 2.04 billion euros
Read MoreTo Donate 100 Million Doses Of Hydroxychloroquine Across 50 Countries
Sanofi called for coordination among the entire hydroxychloroquine chain worldwide to ensure the continued supply of the medicine if proven to be a well-tolerated and effective treatment in COVID-19 patients.
Read MoreSanofi, Regeneron Expand Testing Of Potential Coronavirus Treatment
Italy and Spain have been two of the worst-hit countries in Europe, recording the highest and the second highest death toll from coronavirus of any country in the world, respectively.
Read More